Status:
COMPLETED
Cytokine Hemoadsorption in ECMO Patients
Lead Sponsor:
University Medical Centre Ljubljana
Conditions:
SIRS
Cytokine Storm
Eligibility:
All Genders
18+ years
Brief Summary
Cytokine hemoadsorption is a novel therapy used to improve outcome in critically ill patients with a dysregulated cytokine response and hemodynamic instability. Patients on extracorporeal membraneous ...
Eligibility Criteria
Inclusion
- VA/VV ECMO
- hemoadsorption
- Age ≥ 18 years
Exclusion
- no additional exclusion criteria after being eligible for ECMO
Key Trial Info
Start Date :
June 1 2017
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
January 31 2021
Estimated Enrollment :
25 Patients enrolled
Trial Details
Trial ID
NCT04901338
Start Date
June 1 2017
End Date
January 31 2021
Last Update
May 25 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University Medical Center Ljubljana
Ljubljana, Slovenia, 1000